Which laboratory test is used to adjust warfarin therapy?
5 Laboratory Monitoring of Antithrombotic Therapy Online Quiz Questions
Use this free practice quiz with 20 questions to review 5 Laboratory Monitoring of Antithrombotic Therapy, test your knowledge, and prepare for your next test or exam.
True or false: Most patients receiving standard low-molecular-weight heparin therapy need routine anti-Xa testing to adjust their dose.
- A
True
- B
False
A common target INR range for many warfarin indications is to , although the patient's prescribed target should be followed.
True or false: Routine PT/INR and aPTT tests measure the intended antiplatelet effect of aspirin and clopidogrel.
- A
True
- B
False
A patient taking rivaroxaban has a prolonged PT. Can the INR be used to determine the intensity of treatment?
- A
Yes. INR standardizes the PT result for rivaroxaban just as it does for warfarin.
- B
Yes, if the PT is prolonged, the INR gives a reliable estimate of treatment intensity.
- C
No. INR is not a standardized measure of rivaroxaban intensity.
- D
No. A prolonged PT proves that the patient has excessive anticoagulation.
For unfractionated heparin, what assay may be preferred when a baseline abnormality or lupus anticoagulant makes aPTT unreliable?
A patient taking apixaban has normal PT/INR and aPTT results. Does this prove there is no clinically relevant drug effect?
- A
Yes. Normal results prove that apixaban has no clinically relevant effect.
- B
No. Normal results do not reliably rule out a clinically relevant apixaban level.
- C
Yes, provided both tests are normal.
- D
No. These results prove that the patient has excessive apixaban activity.
Which assay is highly sensitive to dabigatran, so a normal result can help exclude a clinically relevant drug effect?
A patient receiving intravenous unfractionated heparin has an unexpectedly prolonged aPTT. Which actions or checks should be considered before changing the dose? Select all that apply.
- A
Check the institutional heparin protocol and therapeutic range.
- B
Assume that any prolonged aPTT always means the dose must be reduced immediately.
- C
Review specimen collection and timing.
- D
Consider whether aPTT is reliable for this patient.
Besides the anticoagulation assay, which findings are important to follow during heparin treatment? Select all that apply.
- A
Follow the platelet count.
- B
Follow hemoglobin and hematocrit.
- C
Use a single platelet value alone to determine whether HIT is present.
- D
Investigate evidence of blood loss.
When interpreting an anticoagulant test result alongside the medication, dose, and timing of the last dose, also consider function.
A patient taking dabigatran has a prolonged thrombin time. What can that result alone establish about the amount of clinically important drug remaining?
- A
It proves that no dabigatran remains.
- B
It directly quantifies the amount of clinically important dabigatran.
- C
It does not, by itself, quantify how much clinically important dabigatran remains.
- D
It gives a standardized measure of dabigatran intensity equivalent to INR for warfarin.
A patient taking an anticoagulant reports black stools and new dizziness, although the most recent coagulation test was normal. Explain how this should be interpreted and outline the immediate assessment priorities.
What does a high INR generally indicate in a patient taking warfarin?
- A
A high INR generally indicates increased anticoagulant effect and bleeding risk.
- B
A high INR generally indicates inadequate protection from clotting.
- C
A low INR generally indicates increased anticoagulant effect and bleeding risk.
- D
The same INR target applies to every patient taking warfarin.
Which statement about using the aPTT to assess low-molecular-weight heparin effect is correct?
- A
The aPTT is the standard measure of low-molecular-weight heparin effect.
- B
The aPTT is not a suitable measure of low-molecular-weight heparin effect.
- C
PT/INR is required to measure low-molecular-weight heparin effect.
- D
Thrombin time is required for routine monitoring of low-molecular-weight heparin.
Which statement best describes the role of platelet-function testing for patients taking aspirin or clopidogrel?
- A
Platelet-function testing is required for every patient taking aspirin or clopidogrel.
- B
Platelet-function testing routinely determines the appropriate dose for these drugs.
- C
Platelet-function testing is reserved for selected clinical situations and does not routinely guide treatment.
- D
Platelet-function testing replaces assessment for bleeding or thrombosis.
True or false: A normal result on a routine clotting test reliably excludes the effect of every anticoagulant.
- A
True
- B
False
When laboratory assessment of dabigatran effect is clinically necessary, which testing approach can measure the effect?
- A
A dilute thrombin time or an ecarin-based assay
- B
PT/INR alone
- C
Platelet count alone
- D
A routine aPTT as a precise measure of the drug level
What prothrombotic adverse reaction should be considered when a patient has a substantial platelet fall during heparin exposure?
If a drug level is needed for a patient taking rivaroxaban, which assay should be used when available?
Related study packs and tools
- Quiz
1 Principles of Fundamental Care
A medium-difficulty quiz on applying person-centred principles of fundamental care, including dignity, choice, safety, independence, infection prevention, and observation.
- Study guide
1 Scene Assessment and Emergency Priorities
Learn how to make an emergency scene safer, rapidly identify and address immediate threats to life, prioritize patients, and reassess as conditions change.
- Study guide
2 Immediate Stabilization Decisions
A practical guide to recognizing immediate threats, providing appropriate first aid while EMS is coming, and prioritizing emergency transport decisions.
- Quiz
3 Prioritizing Hypotheses
A medium-difficulty quiz on generating plausible hypotheses, comparing urgency and risk, explaining priorities, and revising them as patient cues change.
NCLEX-RN Clinical JudgmentUpdated - Quiz
4 Destination Decisions and Transport Planning
A medium-difficulty quiz on selecting and communicating an appropriate patient destination using patient needs, facility capabilities, travel conditions, and local protocols.
- Study guide
4 Destination Decisions and Transport Planning
Learn how to select and communicate a patient destination by matching clinical risk and likely care needs to facility capability, travel conditions, and local EMS protocols.
- Study guide
4 Patient Identification
Learn how to verify a patient’s identity safely before care, what to do when information does not match, and how to proceed when a patient cannot confirm their identity.
- Study guide
4 Prioritize Hypotheses
Learn how to compare plausible explanations for a client’s findings and prioritize the concern that poses the greatest immediate risk.
- Quiz
5 Generate Solutions
A medium-difficulty quiz on setting measurable patient goals and selecting, implementing, and evaluating interventions that address the priority problem.
- Study guide
5 Urinary and Bowel Elimination
Learn how to support safe, comfortable, and independent toileting, provide elimination and skin care, and recognize changes that require reporting or urgent attention.
- Study guide
6 Take Action
Learn how to implement safe, prioritized nursing interventions, respond to deterioration, communicate concerns, and reassess patient outcomes.
- Quiz
8 Integrated NGN Case Studies
Practice applying the NGN clinical judgment steps, using common item formats, and interpreting client changes.